Moderate Hypofractionation Shows Good Safety Outcomes in Breast Cancer
Safety profile, cosmesis, quality of life improved for MHF versus conventional fractionation
Tusamitamab Ravtansine Does Not Extend Survival With Nonsquamous NSCLC
Findings seen in patients previously treated with platinum-based chemotherapy and immunotherapy whose tumors highly expressed CEACAM5
Risk for Venous Thromboembolism Up for Those With Sickle Cell Trait
Risk for pulmonary embolism was higher than that of isolated deep vein thrombosis in SCT
Perioperative Nivolumab Beneficial for Resectable NSCLC
Perioperative nivolumab showed event-free survival benefit from time of surgery compared with neoadjuvant nivolumab
Risk for Second Primary Cancer May Be No Higher With CAR T-Cell Versus Standard...
Most common SPM subtypes were hematologic malignancies followed by solid tumors, nonmelanoma skin cancers
Long-Course Chemoradiotherapy Preferred TNT Regimen for Rectal Cancer
LCCRT results in higher two-year organ preservation and lower two-year local regrowth compared with short-course radiotherapy
Alternative Explanation Conditions Often Delay Lung Cancer Diagnosis
Having two or more alternative explanation conditions delays lung cancer diagnosis by 74 days
Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer
However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor
Melanoma Incidence, Mortality Declining in Those Aged 30 to 49 Years
Melanoma incidence decreased for those aged 20 to 29, 30 to 39, 40 to 49 years; decline in melanoma mortality seen for those aged 30 to 59 years
Palliative Low-Dose Radiotherapy Improves Pain in Hepatic Cancer
Improvement in hepatic pain seen in 67 percent of patients receiving radiotherapy plus best supportive care
